ArticleThe Journal of experimental medicine2022

CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure.

Yang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.